Bortezomib shows promise in patients with previously untreated multiple myeloma

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2004年 / 18卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1438 / +
页数：2
相关论文
共 50 条
  • [31] Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma
    Huang, Shang-Xiao
    Luo, Peng-Hui
    Wang, Han-Lei
    Mo, Dun-Chang
    Huang, Jian-Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (14) : 2667 - 2668
  • [32] Combination of Vorinostat Plus Bortezomib for the Treatment of Patients with Multiple Myeloma Who Have Previously Received Bortezomib
    Weber, Donna M.
    Jagannath, Sundar
    Sobecks, Ronald
    Schiller, Gary
    Chiacchierini, Lisa
    Reiser, David
    Oerth, Carol
    Garcia-Vargas, Jose
    Rizvi, Syed
    BLOOD, 2008, 112 (11) : 1272 - 1272
  • [33] A phase II study of a modified pegylated liposomal doxorubicin (PLD), bortezomib and dexamethasone regime for patients with previously untreated multiple myeloma (MM)
    Berenson, J. R.
    Yellin, O.
    Chen, C.
    Patel, R.
    Bessudo, A.
    Boccia, R. V.
    Yang, H.
    Gupta, V.
    Hilger, J.
    Swift, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] The only bortezomib at the forefront in previously untreated multiple myeloma is effective. Is initial or secondary neuropathy a barrier to treatment?
    Debarri, Houria
    Leleu, Xavier
    HEMATOLOGIE, 2009, 15 (05): : 327 - 328
  • [35] Reduced dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma.
    Popat, R
    Oakervee, HE
    Curry, N
    Foot, N
    Morris, C
    Drake, M
    Agrawal, S
    Smith, P
    Schenkein, D
    Esseltine, DL
    Cavenagh, JD
    BLOOD, 2005, 106 (11) : 717A - 718A
  • [36] Impact Of Route Of Bortezomib (B) Administration On Dose Intensity and Time To Dose Reduction In Previously Untreated Patients (Pts) With Multiple Myeloma (MM)
    Rifkin, Robert M.
    Chen, Clara
    Dhanda, Rahul
    Rembert, Debra
    Ba-Mancini, Abbie
    Ma, Esprit
    Zhu, Yanyan
    Dow, Edward
    Niculescu, Liviu
    BLOOD, 2013, 122 (21)
  • [37] Thalidomide for previously untreated indolent or smoldering multiple myeloma
    Rajkumar, SV
    Dispenzieri, A
    Fonseca, R
    Lacy, MQ
    Geyer, S
    Lust, JA
    Kyle, RA
    Greipp, PR
    Gertz, MA
    Witzig, TE
    LEUKEMIA, 2001, 15 (08) : 1274 - 1276
  • [38] Thalidomide for previously untreated indolent or smoldering multiple myeloma
    SV Rajkumar
    A Dispenzieri
    R Fonseca
    MQ Lacy
    S Geyer
    JA Lust
    RA Kyle
    PR Greipp
    MA Gertz
    TE Witzig
    Leukemia, 2001, 15 : 1274 - 1276
  • [39] Thalidomide alone or with dexamethasone for previously untreated multiple myeloma
    Weber, D
    Rankin, K
    Gavino, M
    Delasalle, K
    Alexanian, R
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 16 - 19
  • [40] Novel multiple myeloma therapy combination shows promise
    Hargrave, Emily
    FUTURE ONCOLOGY, 2014, 10 (09) : 1532 - 1533
12345